These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 3938639

  • 1. Kinetics of the inhibitor of factor VIII:C in patients with hemophilia A. A study of the cooperative group of hemophilia.
    Ambriz-Fernández R, Reyna-Fregoso MP, Pizzuto-Chávez J, Rodríguez-Moyado H, Farfán-Canto JM, Trueba-Christy E, Collazo-Jaloma J.
    Arch Invest Med (Mex); 1985; 16(3):225-35. PubMed ID: 3938639
    [No Abstract] [Full Text] [Related]

  • 2. A 1973 look at hemophilia and von Willebrand's disease.
    Ratnoff OD.
    Proc Inst Med Chic; 1973; 29(9):296-304. PubMed ID: 4581203
    [No Abstract] [Full Text] [Related]

  • 3. [Determination of factor VIII-coagulation antigen in factor VIII concentrates using an inhibitor test].
    Im T, Hintz G.
    Arzneimittelforschung; 1986; 36(1):124-6. PubMed ID: 3082340
    [Abstract] [Full Text] [Related]

  • 4. Factor VIII/von Willebrand factor.
    Zimmerman TS, Ruggeri ZM, Fulcher CA.
    Prog Hematol; 1983; 13():279-309. PubMed ID: 6422506
    [No Abstract] [Full Text] [Related]

  • 5. [Determination of factor VIII antigen (VIIIR-Ag) by erythrocyte agglutination].
    Coelho E.
    Rev Hosp Clin Fac Med Sao Paulo; 1987; 42(6):273-6. PubMed ID: 3138751
    [No Abstract] [Full Text] [Related]

  • 6. [Processing data for predicting hemophilia transmission].
    Sikorová J, Zvárová J, Paluska E, Vorlová Z.
    Vnitr Lek; 1984 Aug; 30(8):764-70. PubMed ID: 6438902
    [No Abstract] [Full Text] [Related]

  • 7. Unsuitability of laser nephelometer in the evaluation of factor VIII antigen.
    Ruzza G, Viero M, Lazzaro AR, Girolami A.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989 Aug; 116(2):269-75. PubMed ID: 2475407
    [Abstract] [Full Text] [Related]

  • 8. Factor VIII competitive enzyme assay: observations in von Willebrand's variants and hemophiliacs.
    Yorde LD, Yorde DE, Sasse EA, Hussey CV.
    Clin Physiol Biochem; 1984 Aug; 2(6):298-303. PubMed ID: 6440727
    [Abstract] [Full Text] [Related]

  • 9. [Preliminary experience with achieving immune tolerance in patients with hemophilia A and circulating factor VIII inhibitor].
    Scharf R, Kucharski W, Lopaciuk S, Celińska W, Dmytrow A, Domański K, Gonet S, Miastkowski Z, Nowakowska I, Przybylski A.
    Acta Haematol Pol; 1991 Aug; 22(1):92-9. PubMed ID: 1823972
    [Abstract] [Full Text] [Related]

  • 10. [Development of a competitive enzyme immunoassay for factor VIII-related antigen].
    Riemer J, Kopperschläger G.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984 Aug; 111(1):72-83. PubMed ID: 6202602
    [Abstract] [Full Text] [Related]

  • 11. [Acquired hemophilia A due to factor VIIIC inhibitor: detection of circulating immune complexes containing factor VIIIC but not factor VIIIR].
    Pfyffer M, Kistler HJ, von Felten A.
    Schweiz Med Wochenschr; 1983 Oct 08; 113(40):1456-9. PubMed ID: 6417777
    [Abstract] [Full Text] [Related]

  • 12. Gel filtration patterns of factor VIII coagulant antigen and factor VIII related antigen in normal and von Willebrand's disease.
    Chediak J, Peake I, Bloom A.
    Thromb Haemost; 1983 Aug 30; 50(2):509-12. PubMed ID: 6415844
    [Abstract] [Full Text] [Related]

  • 13. The type of factor VIII deficient plasma used influences the performance of the Nijmegen modification of the Bethesda assay for factor VIII inhibitors.
    Verbruggen B, Giles A, Samis J, Verbeek K, Mensink E, Novákovà I.
    Thromb Haemost; 2001 Dec 30; 86(6):1435-9. PubMed ID: 11776311
    [Abstract] [Full Text] [Related]

  • 14. Immune tolerance induction with highly purified plasma-derived factor VIII containing von Willebrand factor in hemophilia A patients with high-responding inhibitors.
    Orsini F, Rotschild C, Beurrier P, Faradji A, Goudemand J, Polack B.
    Haematologica; 2005 Sep 30; 90(9):1288-90. PubMed ID: 16154861
    [Abstract] [Full Text] [Related]

  • 15. [Inhibitors and "bypass" therapy in hemophilia].
    Fukutake K, Fukutake K.
    Nihon Rinsho; 1981 Sep 30; 39(12):3688-99. PubMed ID: 6803034
    [No Abstract] [Full Text] [Related]

  • 16. Absence of anamnestic response after transfusion of washed red blood cells in haemophilia A patients with antibody to factor VIII.
    Laurian Y, Girma JP, Allain JP, Verroust F, Larrieu MJ.
    Scand J Haematol; 1982 Mar 30; 28(3):233-7. PubMed ID: 6806896
    [Abstract] [Full Text] [Related]

  • 17. [Hemorheologic and coagulation study in a group of patients with diabetic retinopathy].
    Parenti M, Pasquali R, Sorrenti G, Babini AC, Melchionda N, Palareti G, Poggi M, Tricarico G.
    G Clin Med; 1984 Mar 30; 65(9-10):409-18. PubMed ID: 6442246
    [No Abstract] [Full Text] [Related]

  • 18. [Use of factors VIII:C and VIIIR:Ag in the detection of classic hemophilia. Study of 40 cases].
    Ambríz-Fernández R, Reyna-Fregoso MP, Cruz ML, Avilés A, García MA, Morales MR, Pizzuto J.
    Rev Invest Clin; 1984 Mar 30; 36(3):257-63. PubMed ID: 6440253
    [No Abstract] [Full Text] [Related]

  • 19. Cold storage of citrated whole blood induces drastic time-dependent losses in factor VIII and von Willebrand factor: potential for misdiagnosis of haemophilia and von Willebrand disease.
    Böhm M, Täschner S, Kretzschmar E, Gerlach R, Favaloro EJ, Scharrer I.
    Blood Coagul Fibrinolysis; 2006 Jan 30; 17(1):39-45. PubMed ID: 16607078
    [Abstract] [Full Text] [Related]

  • 20. Progress and problems in hemophilia and von Willebrand's disease.
    Abildgaard CF.
    Adv Pediatr; 1984 Jan 30; 31():137-77. PubMed ID: 6440429
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.